查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944422

全球出血性中风治疗器械市场：按器械类型、中风类型、手术类型、最终用户、国家和地区划分－产业分析、市场规模、份额和预测（2025-2032年）

Hemorrhagic Stroke Treatment Devices Market, By Device Type, By Stroke Type, By Procedure Type, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 327 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2024 年，出血性中风治疗设备市场规模将达到 10.8423 亿美元，从 2025 年到 2032 年，复合年增长率将达到 7.12%。

出血性中风治疗器械市场专注于用于治疗出血性中风的医疗设备，主要包括脑出血、蜘蛛网膜下腔出血和脑动脉瘤破裂。这些事件被视为医疗急症，器械的选择会影响止血速度、预防再出血以及病患的復健进程。此市场涵盖血管内介入器械（例如弹簧圈、血流导引装置和支架辅助系统），用于从血管内部封闭动脉瘤；以及外科手术器械，例如动脉瘤夹，用于必要时开颅手术。

需求与人口老化、高血压和血管风险以及介入神经放射学医院数量的增加等因素有关。该市场的采购决策通常基于临床结果、安全性和併发症率、在复杂解剖结构中的易用性、与现有医院系统的兼容性以及每次治疗的总成本，而产品性能和证据是供应商之间竞争的关键因素。

出血性中风治疗器材的市场动态

卒中负担日益加重以及卒中中心就诊便利性的提高，正在推动出血性卒中治疗设备的广泛应用。

出血性中风治疗器械市场的主要驱动因素是中风负担的持续加重和中风诊疗体系的稳步扩展，这促使越来越多的患者前往能够进行动脉瘤修復和其他神经血管手术的医院就诊。在美国，卒中仍然是一个重要的公共卫生问题：根据美国疾病管制与预防中心 (CDC) 发布的《2023-2024 年卒中最新情况报告》，卒中每年影响数十万人，是导致长期残疾的主要原因之一，这促使医院继续致力于改善急性卒中诊疗路径和临床疗效。在全球范围内，卒中对死亡率的影响仍然很高。根据世界卫生组织 (WHO) 发布的《2022-2024 年卒中最新情况报告》，卒中是全球主要死因之一，高血压和人口老化仍然是其危险因子。系统性变革也至关重要，因为诊疗路径和医疗网络会影响现有医疗机构的手术量。根据美国联邦和州公共卫生/紧急医疗服务（EMS）卒中系统2020年至2024年收集的数据（包括HRSA支持的和各州卒中项目报告），越来越多的地区正在加强卒中分诊和转诊通讯协定，并将重症卒中病例集中到卓越中心。这些中心使用血管内和外科器械的比例较高。对于医院采购负责人和介入神经放射学团队而言，这直接增加了对弹簧圈、血流导向装置、支架和夹闭系统的需求，这些器械有助于降低再出血风险、提高手术安全性并缩短ICU和住院时间。

出血性中风治疗设备市场：細項分析

导管介入治疗路径正日益普及，尤其是在动脉瘤相关出血方面，因为这种路径允许患者在专科中心快速接受治疗，并在许多情况下减轻开颅手术的负担。总体而言，患者数量仍然庞大：根据美国疾病管制与预防中心 (CDC) 发布的 2023-2024 年卒中最新数据，美国每年有数十万人发生卒中，这维持了活跃的卒中急救流程和充足的神经血管介入器械供应，以应对复杂的病例。随着卒中系统不断完善路径和医疗网络，就医途径也持续改善。根据 2020-2024 年各州卫生部门中风系统计画和急诊转诊通讯协定更新，越来越多的地区正在实施结构化的分流规则，将重症中风患者转诊至高水准的中风中心。这导致符合血管内修復（使用弹簧圈、支架和血流导向技术）条件的出血性中风病例数量增加。从采购方面来看，这推动了对能够应对复杂解剖结构、简化手术流程、减少延长加护病房(ICU) 住院时间的併发症的设备的需求。

临床需求也会因出血发生在脑组织内部还是周围而有所不同，这会影响所需器械的类型和最终治疗的速度。全球疾病负担依然沉重：根据世界卫生组织（WHO，2022-2024 年更新）的数据，中风仍然是全球首要死因，而高血压和人口老化等长期因素加剧了中风的高风险。医院工作流程的压力促使医院加快诊断和治疗准备。根据美国医疗保险和医疗补助服务中心（CMS）发布的 2020-2024 年住院品质计画更新报告，医院在持续品管和报告要求下运营，这强化了标准化的急性护理流程。这推动了对中风团队能力的投入，并确保手术器械随时可用。对于医院董事会和介入神经放射学团队而言，这通常意味着需要能够提高动脉瘤固定速度和一致性、降低再出血风险和手术相关併发症的器械平台。

出血性中风治疗设备市场—区域分析

从区域层面来看，拥有完善的中风网路和足够多的专科医院（提供全天候介入神经放射学服务）的医疗系统，对出血性中风治疗设备的需求可能会更高。北美和欧洲部分地区普遍受益于完善的分诊系统以及医院对先进手术的积极投资。同时，亚太地区拥有庞大的病患群体，主要城市的先进医院能力也不断提升。临床需求的规模仍然是关键的根本驱动因素：根据美国疾病管制与预防中心（CDC，2023-2024 年更新数据），美国每年发生数十万例中风，这支撑了具备卒中诊疗能力的医院对动脉瘤修復工具和其他神经血管器械的稳定需求。全球范围内的负担依然沉重：根据世界卫生组织（WHO，2022-2024 年更新数据），卒中仍然是全球主要死因之一，长期给急救医疗系统和用于治疗严重出血事件的器械带来巨大压力。

美国出血性中风治疗器材市场—国家分析

美国凭藉其庞大的规模、强大的报销能力以及庞大的医院网络，成为领先的国内市场，这些医院能够保持卒中救治能力并实施新的血管内治疗技术。高昂的卒中负担持续推动着治疗工作：根据美国疾病管制与预防中心（CDC）发布的《2023-2024年卒中最新报告》，卒中仍然是导致严重残疾的主要原因之一，每年影响数十万人。这持续推动医院对快速诊断和介入治疗能力的投资。医院的奖励和工作流程标准也影响采购。根据美国医疗保险和医疗补助服务中心（CMS）发布的《2020-2024年住院支付和品质计划最新报告》，医院在持续报告和绩效考核的背景下运营，并正在加强标准化的急性卒中诊疗路径。这推动了医院采购治疗出血性中风所需的血管内设备和手术器械。

目录

第一章 出血性中风治疗设备市场概述

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章：出血性中风治疗设备的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章 出血性中风治疗设备市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 出血性中风治疗器材市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 出血性中风治疗器材的市场现状

  • 出血性中风治疗设备市场占有率分析（2024 年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 出血性中风治疗设备市场（依设备类型划分）

  • 概述
    • 细分市场占有率分析：依设备类型划分
    • 动脉瘤栓塞装置
    • 分流器
    • 动脉瘤夹
    • 支架辅助栓塞系统
    • 抽吸和血栓清除系统

8. 依中风类型分類的出血性中风治疗设备市场

  • 概述
    • 细分市场占有率分析：依中风类型划分
    • 脑出血（ICH）
    • 蛛网膜下腔出血（SAH）

9. 出血性中风治疗器械市场（依手术类型划分）

  • 概述
    • 细分市场占有率分析：依手术类型
    • 血管内治疗
    • 手术

第十章 依最终用户分類的出血性中风治疗设备市场

  • 概述
    • 细分市场占有率分析：依最终用户划分
    • 医院
    • 专科诊所
    • 门诊手术中心

第十一章 出血性中风治疗设备市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十二章 主要供应商分析－出血性中风治疗设备产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Abbott Laboratories
    • B. Braun SE
    • Balt USA, LLC
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Integer Holdings Corporation
    • Johnson &Johnson Services, Inc.
    • Kaneka Corporation
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • MicroVention, Inc.
    • Natus Medical Incorporated
    • Nihon Kohden Corporation
    • Penumbra, Inc.
    • Phenox GmbH
    • Rapid Medical Ltd.
    • Stryker Corporation
    • Terumo Corporation
    • WL Gore &Associates, Inc.
    • Wallaby Medical Holding, Inc.
    • Others

第十三章：分析师视角360度分析

简介目录
Product Code: ANV6063

Hemorrhagic Stroke Treatment Devices Market size was valued at US$ 1,084.23 Million in 2024, expanding at a CAGR of 7.12% from 2025 to 2032.

The hemorrhagic stroke treatment devices market focuses on medical devices used to manage bleeding-type strokes, mainly intracerebral hemorrhage and subarachnoid hemorrhage, including cases linked to ruptured brain aneurysms. These events are treated as medical emergencies, and the choice of devices can affect how quickly bleeding is controlled, whether re-bleeding is prevented, and how patients recover over time. The market includes endovascular tools such as coils, flow diverters, and stent-assisted systems used to seal aneurysms from inside the blood vessel, along with surgical tools like aneurysm clips used in open procedures when required.

Demand is connected to factors such as aging populations, high blood pressure and vascular risk, and the expansion of hospitals with neurointerventional capabilities. Buying decisions in this market are usually based on clinical outcomes, safety and complication rates, how easy devices are to use in complex anatomy, compatibility with existing hospital systems, and the overall cost per treated case, which makes product performance and evidence an important part of vendor competition.

Hemorrhagic Stroke Treatment Devices Market- Market Dynamics

High Stroke Burden and Better Access to Stroke Centers Are Increasing Use of Hemorrhagic Treatment Devices

A major driver for the hemorrhagic stroke treatment devices market is the ongoing stroke burden and the steady expansion of organized stroke care, which increases the number of patients reaching hospitals that can perform aneurysm repair and other neurovascular procedures. Stroke remains a major public health issue in the U.S.: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke updates published during 2023-2024), stroke affects hundreds of thousands of people each year and continues to rank among the leading causes of long-term disability, which keeps hospitals focused on improving acute stroke pathways and clinical outcomes. Globally, the overall mortality impact stays high: According to World Health Organization (WHO) updates released during 2022-2024, stroke remains among the top causes of death worldwide, with hypertension and aging populations continuing to support risk levels. System changes also matter because routing and treatment networks influence procedure volume at capable sites: According to U.S. government and state public health/EMS stroke-system materials compiled across 2020-2024 (including HRSA-supported and state stroke program reporting), more regions have strengthened stroke triage and destination protocols, which increases the concentration of severe stroke cases at higher-level centers where endovascular and surgical device use is more common. For hospital buyers and neurointerventional teams, this directly supports demand for coils, flow diverters, stents, and clipping systems that can reduce re-bleeding risk, improve procedural safety, and help shorten ICU and hospital stays.

Hemorrhagic Stroke Treatment Devices Market- Segmentation Analysis:

More hemorrhagic stroke care is moving toward catheter-based treatment pathways, especially for aneurysm-related bleeding, because these procedures can be performed faster in specialized centers and can reduce the burden of open surgery in many cases. The overall volume base remains large: According to the U.S. Centers for Disease Control and Prevention (CDC, stroke information updated during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, keeping emergency stroke workflows active and supporting steady use of neurovascular devices in hospitals that can treat complex cases. Access factors also keep improving because stroke systems continue to formalize routing and care networks: According to state health department stroke-system plans and EMS destination protocol updates published during 2020-2024, more regions have implemented structured triage rules that direct severe stroke patients to higher-capability stroke centers, which increases the number of hemorrhagic cases evaluated for endovascular repair using coils, stents, and flow-diversion technologies. In purchasing terms, this pushes demand toward devices that can navigate difficult anatomy, simplify procedure steps, and reduce complications that extend ICU stays.

Clinical needs also differ based on whether bleeding occurs inside the brain tissue or around the brain, and this affects which tools are required and how quickly definitive treatment must happen. The broader disease burden remains serious globally: According to World Health Organization (WHO, updates released during 2022-2024), stroke continues to rank among the top causes of death worldwide, and long-term drivers such as hypertension and aging populations keep the risk environment high. Hospital workflow pressure supports faster diagnosis and treatment readiness: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient and quality program updates released during 2020-2024, hospitals operate under ongoing quality and reporting expectations that reinforce standardized acute-care processes, which support investment in stroke-team capability and procedure-ready device availability. For hospital committees and neurointerventional teams, this generally translates into demand for device platforms that improve speed and consistency during aneurysm securing and reduce the risk of re-bleeding and procedure-related complications.

Hemorrhagic Stroke Treatment Devices Market- Geographical Insights

Geographically, demand for hemorrhagic stroke treatment devices tends to be higher in healthcare systems that have organized stroke networks and enough specialized hospitals to run neurointerventional services around the clock. North America and parts of Europe generally benefit from established triage systems and strong hospital spending on advanced procedures, while Asia-Pacific has a large patient base and is expanding higher-level hospital capabilities in major cities. The size of the clinical need remains a major baseline driver: According to the U.S. Centers for Disease Control and Prevention (CDC, updates published during 2023-2024), stroke affects hundreds of thousands of people each year in the United States, which supports consistent demand for aneurysm-repair tools and other neurovascular devices in stroke-capable hospitals. The global burden also stays significant: According to World Health Organization (WHO, updates released during 2022-2024), stroke remains among the top causes of death worldwide, keeping long-term pressure on emergency care capacity and the devices used to treat high-acuity bleeding events.

United States Hemorrhagic Stroke Treatment Devices Market- Country Insights

The United States stands out as a strong country market because of scale, strong reimbursement capacity, and a large base of hospitals that maintain stroke readiness and can adopt newer endovascular technologies. High stroke burden continues to support procedure activity: According to CDC (2023-2024 stroke updates), stroke remains a leading cause of serious disability and still impacts hundreds of thousands of people per year, which keeps hospital investment focused on faster diagnosis and intervention capability. Hospital incentives and workflow standards also influence procurement: According to the U.S. Centers for Medicare & Medicaid Services (CMS) inpatient payment and quality-program updates released during 2020-2024, hospitals operate under ongoing reporting and performance expectations that reinforce standardized acute stroke pathways, supporting purchasing of endovascular device inventories and surgical tools needed for hemorrhagic stroke care.

Hemorrhagic Stroke Treatment Devices Market- Competitive Landscape:

The competitive landscape is led by companies with deep neurovascular portfolios and strong clinical support, since success depends on evidence, physician training, and consistent device performance in complex anatomy. Medtronic plc and Stryker Corporation are often referenced for broad neurovascular product lines and strong positioning in major stroke centers, which helps with hospital standardization and contracting. Terumo Corporation and MicroVention, Inc. are typically linked with catheter and coil systems designed for controlled deployment and access in challenging vessels. Penumbra, Inc. is commonly associated with aspiration and procedure-support systems used in neurointervention settings where speed matters. Boston Scientific Corporation, Abbott Laboratories, and Johnson & Johnson Services, Inc. are usually seen as large-scale competitors with distribution strength and clinical infrastructure, supporting adoption across wider hospital networks. Across these vendors, competitive strength generally comes down to device deliverability, complication management, training programs, and post-market clinical data, which are the main factors used by hospital committees when selecting hemorrhagic stroke treatment platforms.

Recent Developments:

In November 2024, AIIMS Delhi and a consortium of 16 Indian hospitals (public and private hospitals providing advanced stroke care) partnered to launch the GRASSROOT clinical trial to evaluate Gravity Medical Technology's (stroke treatment device developer) stent-retriever designed for mechanical thrombectomy in Indian patients with large vessel occlusion stroke; the program was positioned around India's high stroke burden of about 1.7 million strokes annually, an estimated 375,000 patients who could benefit each year from interventional stroke treatment, and the gap that only about 4,500-5,000 patients received thrombectomy in 2023 due to access and cost, with a stated goal to bring device pricing down to roughly one-quarter of current levels.

In May 2024, IIIT Bangalore (research and engineering institute) unveiled XoRehab (an IoT-enabled rehabilitation wheelchair device) developed through the Centre for the Internet of Ethical Things with support from government and international partners, designed to help stroke patients continue physiotherapy after hospital discharge using surface EMG tracking and a 9-degree-of-freedom assistive suit for upper and lower limb movement; the device was positioned for hospital purchase at around ₹85,000-₹90,000 with a rental model to improve access for patients who struggle to attend frequent in-person therapy sessions.

In September 2021, Hyperfine, Inc. (medical imaging technology company) announced results from a Yale New Haven Hospital study of its FDA-cleared portable MRI system Swoop, showing performance for hemorrhagic stroke detection including 96.6% specificity (85/88) for blood-negative cases and 80.4% sensitivity (45/56) for intracerebral hemorrhage detection across 144 exams, with later-study software versions reaching 90.5% overall accuracy and 85.3% sensitivity (29/34); the company highlighted the bedside design as a way to reduce ICU patient transport risks and support faster stroke assessment where conventional CT/MRI access is limited.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott Laboratories
  • B. Braun SE
  • Balt USA, LLC
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroVention, Inc.
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.
  • Wallaby Medical Holding, Inc.
  • Others

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY DEVICE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Aneurysm Coiling Devices
  • Flow Diverters
  • Aneurysm Clips
  • Stent-Assisted Coiling Systems
  • Aspiration & Thrombectomy Systems

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY STROKE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Intracerebral Hemorrhage (ICH)
  • Subarachnoid Hemorrhage (SAH)

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY PROCEDURE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Endovascular Procedures
  • Surgical Procedures

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

GLOBAL HEMORRHAGIC STROKE TREATMENT DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Hemorrhagic Stroke Treatment Devices Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Hemorrhagic Stroke Treatment Devices Market Snippet by Device Type
    • 2.1.2. Hemorrhagic Stroke Treatment Devices Market Snippet by Stroke Type
    • 2.1.3. Hemorrhagic Stroke Treatment Devices Market Snippet by Procedure Type
    • 2.1.4. Hemorrhagic Stroke Treatment Devices Market Snippet by End User
    • 2.1.5. Hemorrhagic Stroke Treatment Devices Market Snippet by Country
    • 2.1.6. Hemorrhagic Stroke Treatment Devices Market Snippet by Region
  • 2.2. Competitive Insights

3. Hemorrhagic Stroke Treatment Devices Key Market Trends

  • 3.1. Hemorrhagic Stroke Treatment Devices Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Hemorrhagic Stroke Treatment Devices Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Hemorrhagic Stroke Treatment Devices Market Opportunities
  • 3.4. Hemorrhagic Stroke Treatment Devices Market Future Trends

4. Hemorrhagic Stroke Treatment Devices Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Hemorrhagic Stroke Treatment Devices Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Hemorrhagic Stroke Treatment Devices Market Landscape

  • 6.1. Hemorrhagic Stroke Treatment Devices Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Hemorrhagic Stroke Treatment Devices Market - By Device Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Device Type, 2024 & 2032 (%)
    • 7.1.2. Aneurysm Coiling Devices
    • 7.1.3. Flow Diverters
    • 7.1.4. Aneurysm Clips
    • 7.1.5. Stent-Assisted Coiling Systems
    • 7.1.6. Aspiration & Thrombectomy Systems

8. Hemorrhagic Stroke Treatment Devices Market - By Stroke Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
    • 8.1.2. Intracerebral Hemorrhage (ICH)
    • 8.1.3. Subarachnoid Hemorrhage (SAH)

9. Hemorrhagic Stroke Treatment Devices Market - By Procedure Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Procedure Type, 2024 & 2032 (%)
    • 9.1.2. Endovascular Procedures
    • 9.1.3. Surgical Procedures

10. Hemorrhagic Stroke Treatment Devices Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Stroke Type, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Specialty Clinics
    • 10.1.4. Ambulatory Surgical Centers

11. Hemorrhagic Stroke Treatment Devices Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Hemorrhagic Stroke Treatment Devices Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Device Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Stroke Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Procedure Type, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Hemorrhagic Stroke Treatment Devices Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Abbott Laboratories
    • 12.2.2. B. Braun SE
    • 12.2.3. Balt USA, LLC
    • 12.2.4. Boston Scientific Corporation
    • 12.2.5. Cook Medical LLC
    • 12.2.6. Integer Holdings Corporation
    • 12.2.7. Johnson & Johnson Services, Inc.
    • 12.2.8. Kaneka Corporation
    • 12.2.9. Medtronic plc
    • 12.2.10. Merit Medical Systems, Inc.
    • 12.2.11. MicroVention, Inc.
    • 12.2.12. Natus Medical Incorporated
    • 12.2.13. Nihon Kohden Corporation
    • 12.2.14. Penumbra, Inc.
    • 12.2.15. Phenox GmbH
    • 12.2.16. Rapid Medical Ltd.
    • 12.2.17. Stryker Corporation
    • 12.2.18. Terumo Corporation
    • 12.2.19. W. L. Gore & Associates, Inc.
    • 12.2.20. Wallaby Medical Holding, Inc.
    • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us